<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04935463</url>
  </required_header>
  <id_info>
    <org_study_id>2021-13086</org_study_id>
    <nct_id>NCT04935463</nct_id>
  </id_info>
  <brief_title>Mucormycosis in COVID-19</brief_title>
  <acronym>MUNCO</acronym>
  <official_title>Mucormycosis in COVID-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Montefiore Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medanta Institute Delhi</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>AIIMS Patna</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>HCG Oncology Bangalore</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>NSCB Jabalpur</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Montefiore Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose is to allow phsyician reporters to contribute to MUNCO registry. Mucormycosis in&#xD;
      COVID-19 is a rapidly escalating medical emergency reported in high numbers in India during&#xD;
      the ongoing coronavirus surge. There is very little known about the risk factors, patterns&#xD;
      and complications of mucormycosis as it occurs either during the infection or treatment phase&#xD;
      of the novel coronavirus (COVID-19). In light of this emerging epidemic within a pandemic, it&#xD;
      is of time sensitive importance to obtain a better understanding of the risk factors and&#xD;
      outcomes of this fatal complication&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">May 24, 2021</start_date>
  <completion_date type="Anticipated">June 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Vision loss</measure>
    <time_frame>60 days</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Covid19</condition>
  <condition>Mucormycosis</condition>
  <condition>Aspergillosis</condition>
  <condition>Candida Infection</condition>
  <eligibility>
    <study_pop>
      <textblock>
        We have a web-based platform to allow physicians or other healthcare providers to report&#xD;
        cases of confirmed Mucormycosis in patients with COVID 19. Physician reporters will&#xD;
        individually enter de-identified data into a secure, electronic database (REDCap). The case&#xD;
        report form will include items requesting the following information: age, country of&#xD;
        residence, state of residence(within India), name of center/practice/physician reporting&#xD;
        the case, gender, height, weight, patient's history specifics (diabetes, cancer, organ&#xD;
        transplant, neutropenia, prior steroid use and intravenous drug use), COVID severity (&#xD;
        mild/moderate/severe), admission CRP values in mg/dL, COVID treatments prescribed,&#xD;
        Mucormycosis treatment prescribed and site of mucormycosis( rhinocerebral, pulmonary,&#xD;
        cutaneous or gastrointestinal) Once a reporter completes a survey, they will not be able to&#xD;
        access the survey again or update it&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Diagnosed case of Mycotic Infection in COVID-19&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 21, 2021</study_first_submitted>
  <study_first_submitted_qc>June 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 23, 2021</study_first_posted>
  <last_update_submitted>June 21, 2021</last_update_submitted>
  <last_update_submitted_qc>June 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Montefiore Medical Center</investigator_affiliation>
    <investigator_full_name>Shitij Arora</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Aspergillosis</mesh_term>
    <mesh_term>Mucormycosis</mesh_term>
    <mesh_term>Zygomycosis</mesh_term>
    <mesh_term>Candidiasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

